Structure-Based Design of Potent, Selective, and Orally Bioavailable VPS34 Kinase Inhibitors
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- DOE - Office Of Science; INDUSTRY
- OSTI ID:
- 1900949
- Journal Information:
- J. Med. Chem., Vol. 65, Issue (17)
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Identification of Nvp-Bkm120 As a Potent, Selective, Orally Bioavailable Class I P13 Kinase Inhibitor for Treating Cancer
Identification of Nvp-Bkm120 As a Potent, Selective, Orally Bioavailable Class I P13 Kinase Inhibitor for Treating Cancer
The Discovery and Optimization of a Novel Class of Potent, Selective, and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer
Journal Article
·
2013
· J. Biol. Inorg. Chem. 16:857,2011
·
OSTI ID:1089698
+1 more
Identification of Nvp-Bkm120 As a Potent, Selective, Orally Bioavailable Class I P13 Kinase Inhibitor for Treating Cancer
Journal Article
·
2013
· ACS Med. Chem. Lett. 2:774,2011
·
OSTI ID:1089699
+18 more
The Discovery and Optimization of a Novel Class of Potent, Selective, and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer
Journal Article
·
2013
· J. Med. Chem.
·
OSTI ID:1093491
+17 more